Most Recent Articles about TEVA
3 Top Stocks You Can Buy and Hold for the Next Decade https://www.fool.com/investing/2020/09/19/3-top-stocks-you-can-buy-and-hold-for-the-next-dec/?source=iedfolrf0000001 Sep 19, 2020 - Companies that are built to last are worth considering for your longer-term money, even amid a crisis.
Satsuma Plunges on Disappointing Data on Migraine Treatment http://www.zacks.com/stock/news/1057087/satsuma-plunges-on-disappointing-data-on-migraine-treatment?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1057087 Sep 11, 2020 - Satsuma (STSA) tanks as late-stage study of STS101 (dihydroergotamine [DHE] nasal) powder as an acute treatment for migraine disappoints.
Teva Charged In Criminal Antitrust Investigation: What It Means https://seekingalpha.com/article/4372214-teva-charged-in-criminal-antitrust-investigation-what-means?source=feed_tag_israel Sep 02, 2020 - One week ago, the DOJ charged Teva for overcharging customers in an alleged price-fixing conspiracy. In this article, I will take a closer look at what this lawsuit means for Teva.

Related Companies

Name Exchange Price Mkt Cap
ALXN Alexion Pharmaceuticals, Inc. NASDAQ $117.77 $26.25B
MYL Mylan N.V. NASDAQ $37.22 $19.19B
BMRN BioMarin Pharmaceutical Inc. NASDAQ $98.11 $17.42B
GRFS Grifols, S.A. NASDAQ $20.42 $13.96B
SRPT Sarepta Therapeutics, Inc. NASDAQ $152.52 $10.13B
Sector: Health Care > Industry: Major Pharmaceuticals